3 Stocks Under $10 That Raise Our Doubts

Why Stocks Priced Under $10 Catch Our Eye

Stocks trading below $10 often attract attention due to their potential for significant growth and the relatively low cost of options contracts. However, it's important to remember that a low price doesn't always mean a good deal—many of these companies carry considerable risks. We advise investors to approach these opportunities with caution, as some businesses in this category have unstable foundations.

Our Approach: Helping You Make Smarter Investment Choices

At StockStory, our goal is to guide you toward profitable investments and help you steer clear of potential pitfalls. With that in mind, we've identified three stocks under $10 that we recommend avoiding, along with some alternative investment ideas worth considering.

Health Catalyst (HCAT)

Current Price: $1.99

Health Catalyst (NASDAQ:HCAT) specializes in providing data analytics solutions and services to healthcare organizations, aiming to improve clinical, financial, and operational outcomes through its "Health Catalyst Flywheel" methodology.

Reasons to Avoid HCAT:

• Revenue growth over the past two years averaged just 4.4%, falling short of what we expect from software companies.
• Lengthy payback periods for sales and marketing spending suggest slow customer acquisition and intense competition.
• Consistently negative free cash flow raises concerns about when, or if, investments will deliver returns.

With a share price of $1.99, Health Catalyst is valued at 0.5 times its projected sales.

Wabash (WNC)

Current Price: $9.81

Wabash (NYSE:WNC) manufactures semi trailers, liquid transport containers, truck bodies, and other equipment for moving goods, with a history that began with a trailer built on two sawhorses.

Why We Recommend Caution with WNC:

• The company's order backlog has declined by an average of 28.7% over the past two years, suggesting future revenue growth may be weak.
• Returns on capital have deteriorated from already modest levels, indicating recent investments may not be adding value.
• Wabash faces liquidity challenges, which could force it to raise additional capital through share dilution.

At $9.81 per share, Wabash is trading at a forward EV-to-EBITDA ratio of 33.7.

Arbor Realty Trust (ABR)

Current Price: $8.62

Founded in 2003, Arbor Realty Trust (NYSE:ABR) focuses on financing multifamily and commercial real estate, including originating and servicing government-backed mortgage loans.

Why We’re Not Bullish on ABR:

• Net interest income has grown by just 6% annually over the last five years, which is below our expectations for the banking sector.
• Over the past two years, earnings per share have dropped by 31% each year, indicating declining profitability even as revenue fell less sharply.
• The tangible book value per share has decreased by 5.1% annually for the last two years, reflecting challenges in capital management.

Arbor Realty Trust is currently valued at 0.8 times its projected book value, with a share price of $8.62.

Stocks We Prefer

Bonus: Our Top 5 Growth Stock Picks

The most successful stocks often share one key trait: explosive revenue growth. Companies like Meta, CrowdStrike, and Broadcom were all identified early by our AI, delivering returns of 315%, 314%, and 455%, respectively.

Discover which five stocks our system is highlighting this month—completely free.

Our 2020 picks included now-famous names like Nvidia, which soared 1,326% from June 2020 to June 2025, and lesser-known companies such as Tecnoglass, which delivered a 1,754% five-year return.